Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS

被引:379
|
作者
Mahley, Robert W. [1 ,2 ,3 ,4 ,5 ]
Weisgraber, Karl H. [1 ,2 ,4 ,5 ]
Huang, Yadong [1 ,2 ,4 ]
机构
[1] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA
[2] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA
[3] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA
[5] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA
基金
美国国家卫生研究院;
关键词
cholesterol; neurodegeneration; HIV; coronary heart disease; LDL receptor; dysbetalipoproteinemia; heparan sulfate proteoglycans; infectious diseases; evolution; LOW-DENSITY LIPOPROTEINS; AMYLOID-BETA PEPTIDE; CELL-SURFACE RECEPTORS; AMINO-ACID-SEQUENCE; DOMAIN INTERACTION; TRANSGENIC MICE; III HYPERLIPOPROTEINEMIA; HUMAN FIBROBLASTS; NEURONAL CELLS; REMNANT LIPOPROTEINS;
D O I
10.1194/jlr.R800069-JLR200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Apolipoprotein (apo) E has roles beyond lipoprotein metabolism. The detrimental effects of apoE4 in cardiovascular, neurological, and infectious diseases correlate with its structural features (e.g., domain interaction) that distinguish it from apoE3 and apoE2. Structure/function studies revealed that apoE2 is severely defective in LDL receptor binding because of a structural difference that alters the receptor binding region and helped unravel the mechanism of type III hyperlipoproteinemia. ApoE4 is the major genetic risk factor for Alzheimer's disease and sets the stage for neuropathological disorders precipitated by genetic, metabolic, and environmental stressors. ApoE also influences susceptibility to parasitic, bacterial, and viral infections. In HIV-positive patients, apoE4 homozygosity hastens progression to AIDS and death and increases susceptibility to opportunistic infections. jlr The next phase in our understanding of apoE will be characterized by clinical intervention to prevent or reverse the detrimental effects of apoE4 by modulating its structure or blocking the pathological processes it mediates.-Mahley, R. W., K. H. Weisgraber, and Y. Huang. Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS. J. Lipid Res. 2009. S183-S188.
引用
收藏
页码:S183 / S188
页数:6
相关论文
共 50 条
  • [21] Arteriosclerosis, apolipoprotein E, and Alzheimer's disease
    Kalaria, RN
    LANCET, 1997, 349 (9059): : 1174 - 1174
  • [22] Apolipoprotein E, cholesterol and Alzheimer's disease
    Burns, M
    Olm, V
    Duff, K
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S401 - S401
  • [23] Apolipoprotein E in Alzheimer's Disease: An Update
    Yu, Jin-Tai
    Tan, Lan
    Hardy, John
    ANNUAL REVIEW OF NEUROSCIENCE, VOL 37, 2014, 37 : 79 - 100
  • [24] Apolipoprotein E genotyping in Alzheimer's disease
    McKeith, IG
    Morris, CM
    LANCET, 1996, 347 (9017): : 1775 - 1775
  • [25] Apolipoprotein E, memory and Alzheimer's disease
    Soininen, HS
    Riekkinen, PJ
    TRENDS IN NEUROSCIENCES, 1996, 19 (06) : 224 - 228
  • [26] Apolipoprotein E: Structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases
    Huang, Yadong
    Mahley, Robert W.
    NEUROBIOLOGY OF DISEASE, 2014, 72 : 3 - 12
  • [27] Apolipoprotein E in Alzheimer's Disease: Focus on Synaptic Function and Therapeutic Strategy
    Qu, Longjie
    Xu, Shuai
    Lan, Zhen
    Fang, Shuang
    Xu, Yun
    Zhu, Xiaolei
    MOLECULAR NEUROBIOLOGY, 2024, : 3040 - 3052
  • [28] Neuropsychological function and Apolipoprotein E genotype in the preclinical detection of Alzheimer's disease
    Bondi, MW
    Salmon, DP
    Galasko, D
    Thomas, RG
    Thal, LJ
    PSYCHOLOGY AND AGING, 1999, 14 (02) : 295 - 303
  • [29] Apolipoprotein E: From Alzheimer's to sepsis
    Harris, HW
    CRITICAL CARE MEDICINE, 2005, 33 (11) : 2696 - 2697
  • [30] Apolipoprotein E, synaptic plasticity and Alzheimer's disease
    Poirier, J
    Minnich, A
    Davignon, J
    ANNALS OF MEDICINE, 1995, 27 (06) : 663 - 670